The findings, which analyzed data from participants over several years, showed that 6.7% of individuals with ADHD developed mild cognitive impairment or dementia, compared to 3.4% of those without the condition. Dr. Daniel G. Amen, founder of Amen Clinics, suggests these results should shift how clinicians perceive ADHD, moving away from viewing it strictly as a behavioral issue toward recognizing it as a systemic brain-based condition. He emphasizes that the organ producing behavior must be monitored with the same rigor as other vital systems.

While the observational study does not prove a direct causal link between ADHD and Alzheimer's disease, it underscores the need for proactive health management. Dr. Amen advocates for the BRIGHT MINDS framework, an 11-point assessment targeting factors like blood flow, inflammation, sleep, and metabolic health. He maintains that ADHD can complicate the management of these variables, making early intervention and lifestyle modifications critical. Patients concerned about memory symptoms are encouraged to address modifiable risks—such as high blood pressure and physical inactivity—rather than assuming cognitive decline is unavoidable.